Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal.
Fernández-Sanromán Á, Fendler A, Tan BJY, Cattin AL, Spencer C, Thompson R, Au L, Lobon I, Pallikonda HA, Martin A, Byrne F, Franz A, Mikolajczak A, Rahman H, Tippu Z, Shepherd STC, Feng H, Deng D, Rowan A, Pickering L, Furness AJS, Young K, Nicol D, Rudman SM, O'Brien T, Edmonds K, Chandra A, Hazell S, Litchfield K, Kassiotis G, Larkin J, Turajlic S. Fernández-Sanromán Á, et al. Among authors: fendler a. Cancer Discov. 2025 Jan 9:OF1-OF23. doi: 10.1158/2159-8290.CD-24-0499. Online ahead of print. Cancer Discov. 2025. PMID: 39784160
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal.
Fernández-Sanromán Á, Fendler A, Tan BJY, Cattin AL, Spencer C, Thompson R, Au L, Lobon I, Pallikonda HA, Martin A, Byrne F, Franz A, Mikolajczak A, Rahman H, Tippu Z, Shepherd STC, Feng H, Deng D, Rowan A, Pickering L, Furness AJS, Young K, Nicol D, Rudman SM, O'Brien T, Edmonds K, Chandra A, Hazell S, Litchfield K, Kassiotis G, Larkin J, Turajlic S. Fernández-Sanromán Á, et al. Among authors: fendler a. Cancer Discov. 2025 Jan 8. doi: 10.1158/2159-8290.CD-24-0499. Online ahead of print. Cancer Discov. 2025. PMID: 39774619
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder.
Furlano K, Plage H, Hofbauer S, Weinberger S, Ralla B, Fendler A, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Koch S, Adamini N, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Zecha H. Furlano K, et al. Among authors: fendler a. BJUI Compass. 2024 Sep 10;5(11):1081-1089. doi: 10.1002/bco2.431. eCollection 2024 Nov. BJUI Compass. 2024. PMID: 39539567 Free PMC article.
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas.
Kluth M, Hitzschke M, Furlano K, Plage H, Hofbauer S, Weinberger S, Ralla B, Fendler A, de Martino M, Roßner F, Schallenberg S, Elezkurtaj S, Lennartz M, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Koch S, Adamini N, Weischenfeldt J, Klatte T, Minner S, Simon R, Sauter G, Schlomm T, Horst D, Zecha H. Kluth M, et al. Among authors: fendler a. Genes Chromosomes Cancer. 2024 Sep;63(9):e23271. doi: 10.1002/gcc.23271. Genes Chromosomes Cancer. 2024. PMID: 39324446
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease course.
Plage H, Furlano K, Neymeyer J, Weinberger S, Gerdes B, Hubatsch M, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Zecha H, Slojewski M. Plage H, et al. Among authors: fendler a. BJUI Compass. 2024 Apr 2;5(6):585-592. doi: 10.1002/bco2.354. eCollection 2024 Jun. BJUI Compass. 2024. PMID: 38873357 Free PMC article.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Zecha H, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Schallenberg S. Plage H, et al. Among authors: fendler a. BMC Urol. 2024 Apr 24;24(1):96. doi: 10.1186/s12894-024-01482-z. BMC Urol. 2024. PMID: 38658905 Free PMC article.
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Kaczmarek K, Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Ecke T, Hallmann S, Koch S, Adamini N, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Zecha H. Kaczmarek K, et al. Among authors: fendler a. Int Urol Nephrol. 2024 Feb;56(2):499-508. doi: 10.1007/s11255-023-03800-0. Epub 2023 Oct 1. Int Urol Nephrol. 2024. PMID: 37777995 Free PMC article.
52 results